Mad Money: Key points from October 5, 2020 (Monday) episode

Home Forums Investments in the US Summary of CNBC “Mad Money” Episodes Mad Money: Key points from October 5, 2020 (Monday) episode

  • This topic is empty.
Viewing 0 reply threads
  • Author
    Posts
    • #2780

      Summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Monday, October 5, 2020. Links to CNBC sites which contain video clips and transcripts are also listed.

       

      ‘I think what we got today was the removal of uncertainty,’ Jim Cramer says (https://www.cnbc.com/2020/10/05/jim-cramer-i-think-what-we-got-today-was-the-removal-of-uncertainty.html)

      • “There’s nothing the market hates more than uncertainty — take it away and stocks go higher,” CNBC’s Jim Cramer said.
      • “I think what we got today was the removal of uncertainty,” the “Mad Money” host said, pointing to President Donald Trump’s improving condition, Joe Biden’s polling numbers and stimulus talks.
      • If lawmakers can agree on a stimulus bill, the bank stocks “could turn positive, and that would be a big deal, especially because they report next week,” he said

      Beneficiaries of Possible Stimulus: Best Buy (BBY), Home Depot (HD), Lowe’s (LOW), Costco (COST), Walmart (WMT), Target (TGT), Bed Bath & Beyond (BBBY)

      Bull Market in Autos: Carvana (CVNA), Carmax (KMX), Lithia (LAD), AutoNation (AN), Ford

       

      Executive Interview: Bristol-Myers gets ‘potentially revolutionary medicine’ in MyoKardia deal, CEO says (https://www.cnbc.com/2020/10/05/bristol-myers-ceo-a-potentially-revolutionary-drug-in-myokardia-deal.html)

      • “MyoKardia is an important company because they developed a really interesting approach to the treatment of cardiovascular disease, which is a precision approach,” Bristol-Myers Squibb CEO Giovanni Caforio told CNBC.
      • “The lead asset for MyoKardia is mavacamten,” which is a “potentially revolutionary medicine for the treatment of the very serious disease of obstructive HC,” he said in a “Mad Money” interview.
      • “It’s potentially a really important medicine that can be filed with the FDA in the first quarter of next and could launch at the end of next year,” he said.

      Ticker: BMY [the stock is still cheap, love the acquisition]

       

      Executive Interview: Slack Technologies CEO on the ‘misconception’ around the messaging platform (https://www.cnbc.com/video/2020/10/05/slack-technologies-ceo-on-the-misconception-around-the-messaging-app.html)

      Slack Technologies CEO Stewart Butterfield, appearing on “Mad Money,” explained what’s driving the company’s growth.

      Ticker: WORK

       

      If you have any questions or comments on this topic, please start a new topic using its parent forum “Investments in the US”.

      Disclaimer

      ****************************

      Previous Episode Next Episode

       

Viewing 0 reply threads
  • The topic ‘Mad Money: Key points from October 5, 2020 (Monday) episode’ is closed to new replies.
Copied title and URL